| Literature DB >> 31017543 |
Xiaoqing Li1, Shirong Zhou1, Yao Wang1, Hui Lian1, Anxin Zuo1, Kaihua Zhou1, Ling Tong1, Zhujun Zhou1, Jimin Gao1.
Abstract
The granulocyte-macrophage colony-stimulating factor (GM-CSF) can be used to induce a powerful immune response. Based on the specific binding of biotin and streptavidin, SA-hGM-CSF was anchored on the surface of biotinylated tumor cells, which could enhance the anti-tumor effect of tumor cell vaccines in our previous reports, suggesting it would have potential clinical value. Preparation of the biologically active proteins in large-scale production is the basis of clinical application, however, only a small amount of biologically active protein was obtained according to previous studies. In this study, we researched the effects of various factors on the purification and simultaneous renaturation of SA-hGM-CSF fusion protein by single factor experiment and orthogonal experiment. Here, we developed a viable pilot-scale trial in the fermentation, purification, refolding and freeze-drying of SA-hGM-CSF proteins in order to efficiently obtain more biologically active proteins with high purity, which will lay the foundation for industrial production.Entities:
Keywords: SA-hGM-CSF fusion protein; optimization; pilot-scale; purification; refolding
Mesh:
Substances:
Year: 2019 PMID: 31017543 PMCID: PMC6527079 DOI: 10.1080/21655979.2019.1608712
Source DB: PubMed Journal: Bioengineered ISSN: 2165-5979 Impact factor: 3.269